Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 10:18 PM
Study NCT ID:
NCT06073158
Status:
UNKNOWN
Last Update Posted:
2023-10-16
First Post:
2023-06-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Molecular Signatures of Esophageal Atresia
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D004933', 'term': 'Esophageal Atresia'}], 'ancestors': [{'id': 'D004065', 'term': 'Digestive System Abnormalities'}, {'id': 'D004066', 'term': 'Digestive System Diseases'}, {'id': 'D004935', 'term': 'Esophageal Diseases'}, {'id': 'D005767', 'term': 'Gastrointestinal Diseases'}, {'id': 'D000013', 'term': 'Congenital Abnormalities'}, {'id': 'D009358', 'term': 'Congenital, Hereditary, and Neonatal Diseases and Abnormalities'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NON_RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'BASIC_SCIENCE', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 20}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2023-06-23', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-07', 'completionDateStruct': {'date': '2024-06-23', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2023-10-12', 'studyFirstSubmitDate': '2023-06-26', 'studyFirstSubmitQcDate': '2023-10-03', 'lastUpdatePostDateStruct': {'date': '2023-10-16', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-10-10', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2024-06-23', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Comparison of the mRNA expression from esophageal biopsies between long and short term storage', 'timeFrame': 'The biopsies will be collected during the first year of life', 'description': "Transcriptomic profiles will be generated by the identification of mRNA and miRNA expression by 3'RNA-seq and sRNA-seq technologies. Differential expression between long and short term storage will be performed.\\[exploratory and untargeted analysis\\]"}, {'measure': 'Comparison of the metabolites identification from esophageal biopsies between long and short term storage', 'timeFrame': 'The biopsies will be collected during the first year of life', 'description': 'Metabolomic profiles will be generated (untargeted analysis that will include mnulmerous lipids, amino-acids, ...). Differential expression between long and short term storage will be performed. \\[exploratory and untargeted analysis\\]'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['esophageal atresia', 'epigenetic', 'proteomics', 'metabolomics'], 'conditions': ['Esophageal Atresia']}, 'descriptionModule': {'briefSummary': 'Although several studies have revealed signaling pathways as well as genes potentially involved in the development of esophageal atresia (EA), our understanding of the pathophysiology of EA lags behind improvements in the surgical and clinical care of patients born with this anomaly. However, a causative genetic abnormality can be identified in less than 10% of patients, even using more recent next-generation sequencing techniques. As most cases of EA associated with tracheoesophageal fistula (TOF) are sporadic, and the familial recurrence rate is low (1%), this suggests that epigenetic and environmental factors also contribute to the disease. Further investigations are needed to better understand the mechanisms underlying EA. That information can come from the oesophageal biopsies that are collected in routine care and long-term storage at the hospital. However, the impact of the length of the storage is still unknown.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD'], 'maximumAge': '1 Year', 'minimumAge': '1 Day', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Anastomosis group :\n\nBorn with esophageal atresia Anastomosis performed in Lille hospital Parents consent\n\n\\- Control group : Born with esophageal atresia\n\nExclusion Criteria:\n\n* Both groups :\n\nParents refusing to participate in the study'}, 'identificationModule': {'nctId': 'NCT06073158', 'briefTitle': 'Molecular Signatures of Esophageal Atresia', 'organization': {'class': 'OTHER', 'fullName': 'University Hospital, Lille'}, 'officialTitle': 'Oesomics Anastomose Molecular Signatures of Esophageal Atresia Comparison of Biopsies Taken During the First Year of Life With Those Taken During Anastomosis', 'orgStudyIdInfo': {'id': '2022-055'}, 'secondaryIdInfos': [{'id': 'ANR', 'type': 'OTHER_GRANT', 'domain': 'ANR-21-CE17-0042'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'OTHER', 'label': 'Anastomosis group', 'description': 'Esophageal biopsies collected during the anastomosis for the patient with esophageal atresia', 'interventionNames': ['Procedure: Esophageal biopsy collection during anastomosis']}, {'type': 'NO_INTERVENTION', 'label': 'Control group', 'description': 'Esophageal biopsies collected during a standard care endoscopy for patient with esophageal atresia during the first year of life'}], 'interventions': [{'name': 'Esophageal biopsy collection during anastomosis', 'type': 'PROCEDURE', 'description': 'During the anastomosis, the surgeon will collect an esophageal mucosa biopsy', 'armGroupLabels': ['Anastomosis group']}]}, 'contactsLocationsModule': {'locations': [{'zip': '59007', 'city': 'Lille', 'status': 'RECRUITING', 'country': 'France', 'contacts': [{'name': 'Mélanie Leroy, PhD', 'role': 'CONTACT', 'email': 'melanie.leroy@chu-lille.fr', 'phone': '+33625372349'}, {'name': 'Rony Sfeir, MD', 'role': 'SUB_INVESTIGATOR'}, {'name': 'Gottrand Frédéric, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}, {'name': 'Aumar Madeleine, MD', 'role': 'SUB_INVESTIGATOR'}, {'name': 'Tran Léa, MD', 'role': 'SUB_INVESTIGATOR'}], 'facility': 'CHU Lille', 'geoPoint': {'lat': 50.63391, 'lon': 3.05512}}], 'centralContacts': [{'name': 'Mélanie Leroy, PhD', 'role': 'CONTACT', 'email': 'melanie.leroy@chu-lille.fr', 'phone': '+33625372349'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University Hospital, Lille', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}